RGNX reports positive pivotal Phase III data for RGX-202, targeting potential accelerated FDA approval in 2027 for Duchenne muscular dystrophy. Regenxbio announced positive top-line results from the pivotal Phase III trial of RGX-202, its investigational gene therapy for D
Blaize reaffirms 2026 revenue guidance at $130M and projects over $11M in NeoTensr deliveries for Q2 2026. Blaize Holdings Inc. (BZAI) maintained its $130M revenue guidance for 2026 during its Q1 2026 earnings call, citing strong momentum from 2025. The company expects to
Streaming firm targets $16M-$20M adjusted EBITDA in 2026 as it aims for $100 million recurring annual revenue. CuriosityStream (CURI) outlined a 2026 revenue forecast of $75M-$80M during its Q1 2026 earnings call, emphasizing a push toward profitability. The company also s
Autolus Therapeutics maintains its 2026 AUCATZYL revenue guidance amid early U.S. and U.K. launch momentum. Autolus Therapeutics reaffirmed its 2026 revenue guidance of $120M to $135M for AUCATZYL, citing strong early traction in the U.S. and U.K. markets. The company targ
The agtech firm delays its U.S. rice launch to 2029 and confirms liquidity through early 2027 following recent funding. Cibus Inc. (CBUS) secured $37 million in gross proceeds from recent capital raises, extending its cash runway into late Q1 2027. The company cited execut
LGCY reports record Q3 earnings with net income at $3 million and plans to expand student capacity by 1,200-1,500 over two years. Legacy Education reported a 15% year-over-year revenue increase to $21.4 million in Q3 fiscal 2026, driven by campus expansions and higher enro
The software firm cites rising U.S. RFP activity and 26% year-to-date growth in AI Knowledge annual recurring revenue. EGain projected fiscal 2026 revenue of $90.5M to $91.0M, reflecting increased demand for its AI-driven customer engagement solutions. The company attribut
Company maintains full-year guidance with adjusted EBITDA margin of 16%-18% after Q1 revenue of $24.2 million. SoundThinking Inc. (SSTI) confirmed its 2026 revenue outlook of $109 million to $111 million, alongside an adjusted EBITDA margin target of 16% to 18%. The guidan
Figma anticipates $1.422B-$1.428B revenue in 2026 Figma's revenue grew 46% year-over-year to $333 million in Q1 2026. The company expects to raise non-GAAP operating income to $125M-$135M. Figma's growth came from seat expansion, retention, enterprise adoption, n
NextNav Inc. signals potential $200M capital infusion via warrants as FCC reviews proposed rulemaking for its spectrum plans. NextNav Inc. outlined plans for a potential $200M capital raise through warrants during its Q1 2026 earnings call. The move aligns with the FCC’s o